The largest database of trusted experimental protocols

19 protocols using d 10 analyzer

1

Metabolic Biomarkers in Fasting and Postprandial States

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the measurements were made after a 10-h overnight fast. Waist circumference, hip circumference, and blood pressure were measured while participants were barefoot and wearing light clothes after defecation. Blood samples were collected before and 2 h after a fixed breakfast (~300 kcal) for measurement of hemoglobin A1c (HbA1c), fasting lipid profile, fasting and 2-h postprandial plasma glucose (2hPPG), insulin, and C-peptide. Fasting and postprandial plasma glucose levels, lipid concentrations for total cholesterol, triglycerides, and HDL-cholesterol (HDL-c) were measured using an automated enzymatic method (7600-020 Chemical Analyzer, Hitachi, Japan). HbA1c levels were determined by high-performance liquid chromatography (D-10 analyzer, Bio-Rad, Hercules, CA). Fasting and 2-h postprandial plasma insulin and C-peptide were measured by radioimmunoassay (Centaur XP immunoassay system, Siemens Healthcare Diagnostics, New York, NY).
Homoeostasis model assessment (HOMA) was used to estimate basal β-cell function (HOMA-B) and insulin resistance (HOMA-IR). HOMA-B was calculated as [20× fasting insulin (FINS)] / [fasting plasma glucose (FPG)—3.5]. HOMA-IR was calculated as FPG × FINS / 22.5 [14 (link)].
+ Open protocol
+ Expand
2

Standardized Biomarker Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The measurements of height and weight, based on a standardized form, were recorded by the same physician. Body mass index (BMI) was calculated as body weight (kg) divided by the square of the height (m). The blood pressure level was calculated by the mean of two consecutive blood pressure values 10 minutes apart taken in a sitting position. Blood and urine samples were collected after a 10-hour overnight fast. Serum concentrations of total cholesterol (TC), triglycerides (TG), LDL-cholesterol (LDL-c), HDL-cholesterol (HDL-c), fasting plasma glucose, and creatinine (Cr) were obtained via an automated enzymatic method (Hitachi, Japan, 7600-020 autonomic analyzer), and high-pressure liquid chromatography (Bio-Rad, USA, D-10 analyzer) was used to evaluate the HbA1c level. The eGFR was estimated by the simplified MDRD equation [16 (link)]. The concentration of serum CysC was measured by particle-enhanced turbidimetric immunoassay (Hitachi, Japan, 7600-020 autonomic analyzer).
+ Open protocol
+ Expand
3

Comprehensive Clinical Data and Metabolic Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols
General clinical data of the subjects were collected, including gender, age, smoking status, duration of T2DM, body mass index (BMI), and Wagner DFU grade.6 Fasting venous blood was obtained, and blood routine related parameters including white blood cell count (WBC), platelet count (PLT), and lymphocyte count (LYM) were measured using a Sysmex XN‐10 analyzer (Sysmex). The PLR was calculated as the platelet‐to‐lymphocyte ratio. Triglyceride (TG), total cholesterol (TC), high‐density lipoprotein (HDL), low‐density lipoprotein (LDL), and fasting blood glucose (FPG) were measured using an Olympus AU5421 analyzer (Olympus), and glycated hemoglobin (HbA1c) was measured using a Bio‐Rad D10 analyzer (Bio‐Rad).
+ Open protocol
+ Expand
4

Induction of Diabetes in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
CWRU IACUC and LSVAMC ACORP approved the animal protocols employed in this study. C57BL/6J and IL-17A−/− mice were obtained from Jackson Laboratories. Diabetes was induced in 8–10 week old male mice by intraperitoneal injections of streptozotocin (60 mg/kg) on 5 consecutive days, as previously described7 (link)–9 (link). Alternatively, heterozygous and homozygous B6.BKS(D)-LeprdblJ mice (db/db) were examined at 8–10 weeks of age, during spontaneous diabetic onset for systemic IL-17A analysis. Diabetes was defined by non-fasted blood glucose concentrations greater than 250 mg/dl, which was verified using glucose-dehydrogenase-based strips on three consecutive occasions beginning 1 week after the last STZ injection; hyperglycemia was also quantified by hemoglobin A1c levels using a Bio Rad D-10 analyzer. Insulin (0–0.2 U) was administered as needed to maintain proper body weight.
+ Open protocol
+ Expand
5

Biochemical Analyses in Clinical Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipid parameters were analyzed in the Lipid Laboratory of the Institute for Clinical and Experimental Medicine, Prague, Czech Republic, employing a fully automated enzymatic method (COBAS MIRA S analyzer, Roche Diagnostics, Basel, Switzerland), along with enzymatic kits produced by the same manufacturer. LDL-cholesterol was calculated using the Friedewald formula. Serum and urine creatinine were analyzed using an enzymatic assay (Hitachi 902 autoanalyzer, Roche Diagnostics, Basel, Switzerland). Glycosylated hemoglobin (HbA1c) was assessed using HLCP method (D-10 analyzer, Bio-Rad, Hercules, California, USA), whereas urine albumin was determined using an immunoturbidimetry (COBAS MIRA S analyzer, Roche Diagnostics, Basel, Switzerland); both these analyses were performed by the Department of Clinical Biochemistry at the Thomayer University Hospital, Prague, Czech Republic. The accuracy of these analyses was continuously monitored and tested, with external quality control of lipid parameters performed by the Centers for Disease Control and Prevention (Atlanta, Georgia, USA).
+ Open protocol
+ Expand
6

Plasma Glucose and HbA1c Measurement Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma glucose concentration was measured with glucose oxidase method on Beckman Coulter Unicel DXC-800 analyzer. HbA1c was measured using ion-exchange high-performance liquid chromatography (Bio-Rad D-10 analyzer). The reference range of the test was from 3.8% to 18.5%.
Contour® Next glucometer was used for CBG measurements (manufactured by Bayer HealthCare LLC). Fingertips were used for CBG sample using standard lancing device provided by the manufacturer. The test strips used flavin adenine dinucleotide-glucose dehydrogenase method for blood glucose testing.[8 (link)] The results of the glucometer are referenced to plasma/serum blood glucose values. The measuring range of the glucometer is 10–600 mg/dl.
+ Open protocol
+ Expand
7

Evaluating Laboratory Markers in T1D

Check if the same lab product or an alternative is used in the 5 most similar protocols
Laboratory parameters were measured in blood samples in the Department of Laboratory Medicine of the National Institute of Children’s Diseases in Bratislava.
Glucose, pH, and bicarbonate levels were determined using standard laboratory methods. HbA1c was evaluated from whole blood using an HPLC method (D-10 analyzer, Bio-Rad, Hercules, CA, USA). Fasting serum C-peptide levels were determined using the electrochemiluminescence immunoassay method (Cobas e411, Roche Diagnostic, Basel, Switzerland). Pancreatic autoantibodies (against glutamic acid decarboxylase, tyrosine phosphatase, and insulin were detected using commercial ELISA kits (RSR Ltd., Cardiff, UK), according to the manufacturer’s instructions. Mean HbA1c was calculated using all obtained values during the first year of the follow-up. Delta HbA1c was calculated as a difference in HbA1c values at the time of T1D diagnosis and after one year of T1D duration. HbA1c values were transformed to the International Federation of Clinical Chemistry values (http://www.ngsp.org/ifccngsp.asp, accessed on 7 June 2008) and Diabetes Control and Complications Trial values.
+ Open protocol
+ Expand
8

Evaluating Glycemic Control through HbA1c and eAG

Check if the same lab product or an alternative is used in the 5 most similar protocols

The random blood glucose and HbA1c levels of 461 patient samples (178 male and 283 female) were included in the study. Blood samples were taken on the same day for the determination of both RBS and HbA1c. The eAG levels (mg/dL) were calculated using the following formula: 28.7 × HbA1c – 46.7. The samples were divided into four groups on the basis of HbA1c levels as group 1: HbA1c greater than 9% (poorly controlled diabetic), group 2: HbA1c 6.5 to 9% (fairly controlled diabetic), group 3: HbA1c 5.7 to 6.4% (prediabetic), and group 4: HbA1c less than 5.7% (nondiabetic).
8 (link)
Glucose levels were determined using the glucose oxidase method in Transasia Erba analyzer with commercially available Agappe kits. HbA1c levels were determined using high-performance liquid chromatographic method on Biorad D10 analyzer with Biorad kits.
+ Open protocol
+ Expand
9

Biochemical and Lipid Profile Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were analyzed for urea, albumin, total protein, total cholesterol (TC), high density lipoprotein (HDL) cholesterol, triglycerides (TG), uric acid, alkaline phosphatase (ALP), aspartate transaminase (AST) and alanine transaminase (ALT) using Human commercial kits and Humalyzer 3500. Moreover, glycated hemoglobin (HbA1c) test was performed to find out the amount of glycated hemoglobin (HbA1c) using Bio Rad D-10 analyzer. Very low density lipoprotein (VLDL) cholesterol and Low density lipoprotein (LDL) cholesterol concentrations were calculated using the following Friedewald equations [12] (link):

The atherogenic indices were calculated as follows:

[13] (link)

[14] (link)

[15] (link)

[16] (link)
+ Open protocol
+ Expand
10

Comprehensive Metabolic and Renal Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
HbA1c in erythrocytes was measured by high-performance liquid ion exchange chromatography (D-10 analyzer (Bio-Rad, Hercules, CA, USA). The glucose oxidase method was used for measuring capillary glucose. The average daily hyperglycemia was determined.
The serum lipid content (TG, TC, and HDL) was determined using commercial kits (BioSystems, Spain) and a biochemical analyzer (Synchron SH9 Pro, Beckman Coulter, Brea, CA, USA). The levels of LDL were calculated using the Friedewald formula [34 (link)]: LDL = TC − (HDL + VLDL)). The level of VLDL equaled TG/2.2.
Methods used for kidney damage determination in the early studies included a GFR calculation, urinary albumin and ratio of albumin/creatinine. These were determined on a biochemical analyzer (Synchron SH9 Pro, Beckman Coulter, Brea, CA, USA) using the immunoturbidimetric method. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula was used for calculating GFR (mL/min/1.73 m2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!